-

MedMen Opens First Miami Location in South Beach

The Location Will Offer MedMen’s Signature Brands and MedMen Buds Loyalty Program to Miami’s Medical Marijuana Patients

LOS ANGELES--(BUSINESS WIRE)--(“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today announced the opening of its first Miami location in the heart of South Beach on Collins Avenue, just two blocks from the historic Art Deco District and lively beach.

MedMen South Beach will welcome Florida’s medical marijuana card holders with a robust offering including classic and exotic flower strains, pre rolls, vaporizers and edibles from leading brands such as MedMen’s signature house brands MedMen and Luxlyte, with Mary’s Medicinals, Dixie, and Mindset Vaporizers launching in the coming months. Cannabis patients can find a team of knowledgeable associates to provide expert guidance and recommendations for each patient’s unique needs.

In-store or online, patients can opt-in to MedMen Buds national loyalty program to receive exclusive access to sales and discounts. Members earn points for every purchase which can be redeemed for a variety of rewards.

“We are thrilled to become a part of the Miami community with the opening of our MedMen South Beach dispensary,” said Tom Lynch, Chairman and Chief Executive Officer of MedMen. “MedMen has a strong reputation for quality service to the medical marijuana community, and our highly educated associates make shopping with us a breeze, regardless of your experience with cannabis. We remain committed to the highest standards of quality, inclusivity and customer service, and our Miami location deepens our commitment to Florida and the people there.”

“As Senate District 38 continues to grow at a rapid rate, it is important that the people of our community with significant illnesses, such as PTSD and chronic pain, have access to medical cannabis,” said State Senator Jason Pizzo. “To that end, we welcome MedMen to Miami Beach and hope that this is just the beginning of their growth in our community.”

Karen Basha Egozi, President & CEO of Epilepsy Florida said, “We are incredibly excited to work with MedMen and look forward to continuing this partnership as MedMen continues to expand across the state. We are grateful for MedMen’s commitment to providing education on the medicinal effects of cannabis and its potential benefits to the Epilepsy community.”

MedMen South Beach spans 4,263 square-feet and features its signature pristine, high-design look with sleek walnut tables where guests can find educational tablets, hickory ceilings and airy space with pops of MedMen’s signature bold scarlet red.

Address: 550 Collins Ave. Miami Beach, FL 33139. Mon-Sat 10:00AM – 7:00PM/Sun 10:00AM – 5:00PM.

ABOUT MEDMEN:

MedMen is a premier American cannabis retailer with an operational footprint in California, Nevada, Illinois, Arizona, Massachusetts and Florida. MedMen offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red and LuxLyte through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen at www.medmen.com.

Cautionary Note Regarding Forward-Looking Information and Statements:

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only MedMen’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “will” and “can” and “continue”. This forward-looking information is based on certain assumptions made by management and other factors used by management in developing such information. Forward-looking statements contained in this news release are expressly qualified by this cautionary note.

Source: MedMen Enterprises

Contacts

Media Contact:
Erica Ferriso | Quinn PR
eferriso@quinn.pr

Tracy McCourt | MedMen
communications@medmen.com

Investor Relations Contact:
Reece Fulgham | MedMen
investors@medmen.com

MedMen Enterprises Inc.

CNSX:MMEN

Release Summary
MedMen Opens First Miami Location in South Beach
Release Versions

Contacts

Media Contact:
Erica Ferriso | Quinn PR
eferriso@quinn.pr

Tracy McCourt | MedMen
communications@medmen.com

Investor Relations Contact:
Reece Fulgham | MedMen
investors@medmen.com

More News From MedMen Enterprises Inc.

MedMen Announces Management and Board Changes

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e...

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce...

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO (“MCTO”) by its principal regulator, the Br...
Back to Newsroom